NEW YORK (AP) -- Investigators took to media mailrooms across New York after learning that an ABC News producer's infant son was diagnosed with anthrax.
The diagnosis of the 7-month-old child marked the second anthrax case at a major news organization in New York in three days, following one at NBC in which a female employee was infected by a letter carrying anthrax.
ABC News President David Westin said Monday the boy developed the skin form of anthrax after spending time at the newsroom last month. The child is taking antibiotics and is expected to recover.
"The prognosis is excellent," Westin said.
President Bush told reporters "there may be some possible link" between the anthrax incidents and Osama bin Laden, who administration officials say was behind the Sept. 11 terrorist attacks.
"I wouldn't put it past him, but we don't have any hard evidence," Bush said.
In New York, investigators moved into newsroom mailrooms after learning of the ABC case.
At The Associated Press on Monday night, eight police officers -- one wearing a protective biohazard suit complete with respirators -- took spot swipes from the countertops and other surfaces in the mailroom looking for any anthrax residue. The swipes will be tested at a city health department lab.
Other newsroom to be tested included CNN, CBS, Fox, The Daily News, and The New York Post.
Authorities did not discuss the source of the germ involving the child who was believed to have been on two floors of the ABC building for a couple of hours on Sept. 28. Westin said the child is the son of a female producer, but did not release names.
The skin version of anthrax that the boy contracted is not the more-lethal inhaled form that infected two Florida men who worked at a supermarket tabloid, killing American Media, Inc. employee Robert Stevens, 63.
Since then, officials have discovered at least traces of anthrax in New York, Nevada and Washington, D.C. Tests indicate that at least 13 people either have anthrax or were exposed to the anthrax spores.
Brainerd Dispatch ©2013. All Rights Reserved.